These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9660375)

  • 21. D-fenfluramine-induced prolactin and cortisol release in major depression: response to treatment.
    O'Keane V; McLoughlin D; Dinan TG
    J Affect Disord; 1992 Nov; 26(3):143-50. PubMed ID: 1460163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotonin function in detoxified heroin abusers: prolactin and cortisol responses to fenfluramine challenge.
    Gerra G; Fertonani G; Tagliavini P; Zaimovic A; Delsignore R; Maestri D; Avanzini P; Caccavari R; Brambilla F
    Psychiatry Res; 1995 Sep; 58(2):153-60. PubMed ID: 8570767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thyroid axis activity and serotonin function in major depressive episode.
    Duval F; Mokrani MC; Bailey P; Correa H; Diep TS; Crocq MA; Macher JP
    Psychoneuroendocrinology; 1999 Oct; 24(7):695-712. PubMed ID: 10451906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormal serotonergic control of prolactin and cortisol secretion in patients with seasonal affective disorder.
    Coiro V; Volpi R; Marchesi C; De Ferri A; Davoli C; Caffarra P; Rossi G; Caffarri G; Davolio M; Chiodera P
    Psychoneuroendocrinology; 1993; 18(8):551-6. PubMed ID: 8127946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotonergic responsiveness in human cocaine users.
    Ghitza UE; Rothman RB; Gorelick DA; Henningfield JE; Baumann MH
    Drug Alcohol Depend; 2007 Jan; 86(2-3):207-13. PubMed ID: 16930852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma prolactin, adrenocorticotrophic hormone and cortisol after administration of d-fenfluramine or placebo to healthy subjects.
    Gorard DA; Taylor TM; Medbak SH; Perry LA; Libby GW; Farthing MJ
    Int Clin Psychopharmacol; 1993; 8(2):123-8. PubMed ID: 8393895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endocrine responses after d-fenfluramine and ipsapirone challenge: further support for Cloninger's tridimensional model of personality.
    Hennig J; Toll C; Schonlau P; Rohrmann S; Netter P
    Neuropsychobiology; 2000; 41(1):38-47. PubMed ID: 10629434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences between morning and afternoon hormonal responses to D-fenfluramine in healthy humans.
    Monteleone P; Bortolotti F; Orazzo C; Serino I; Maj M
    Psychoneuroendocrinology; 1997 Feb; 22(2):79-87. PubMed ID: 9149330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impulsivity, aggression, and neuroendocrine responses to serotonergic stimulation in substance abusers.
    Fishbein DH; Lozovsky D; Jaffe JH
    Biol Psychiatry; 1989 Apr; 25(8):1049-66. PubMed ID: 2720017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prolactin response to fenfluramine in depression: effects of melancholia and baseline cortisol.
    Mulder RT; Porter RJ; Joyce PR
    J Psychopharmacol; 2003 Mar; 17(1):97-102. PubMed ID: 12680745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serotonin function and risk for alcoholism in boys with attention-deficit hyperactivity disorder.
    Schulz KP; McKay KE; Newcorn JH; Sharma V; Gabriel S; Halperin JM
    Neuropsychopharmacology; 1998 Jan; 18(1):10-7. PubMed ID: 9408914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of d, l-fenfluramine and citalopram challenges in healthy adults.
    Flory JD; Manuck SB; Perel JM; Muldoon MF
    Psychopharmacology (Berl); 2004 Jul; 174(3):376-80. PubMed ID: 14997271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of serotonergic function in major depression using d-fenfluramine: relation to clinical variables and antidepressant response.
    Cleare AJ; Murray RM; O'Keane V
    Biol Psychiatry; 1998 Oct; 44(7):555-61. PubMed ID: 9787879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma prolactin response to D-fenfluramine is blunted in bulimic patients with frequent binge episodes.
    Monteleone P; Brambilla F; Bortolotti F; Ferraro C; Maj M
    Psychol Med; 1998 Jul; 28(4):975-83. PubMed ID: 9723152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional consequences of central serotonin depletion produced by repeated fenfluramine administration in rats.
    Baumann MH; Ayestas MA; Rothman RB
    J Neurosci; 1998 Nov; 18(21):9069-77. PubMed ID: 9787010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retest reliability of prolactin response to dl-fenfluramine challenge in adults.
    Flory JD; Manuck SB; Muldoon MF
    Neuropsychopharmacology; 2002 Feb; 26(2):269-72. PubMed ID: 11790522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroendocrine responses to challenge with dl-fenfluramine and aggression in disruptive behavior disorders of children and adolescents.
    Stoff DM; Pasatiempo AP; Yeung J; Cooper TB; Bridger WH; Rabinovich H
    Psychiatry Res; 1992 Sep; 43(3):263-76. PubMed ID: 1438624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cigarette smoking decreases the prolactin response to serotonergic stimulation in subgroups of alcoholics and controls.
    Anthenelli RM; Maxwell RA
    Alcohol Clin Exp Res; 2000 Jul; 24(7):987-95. PubMed ID: 10924001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Central serotonergic activity is related to the aggressive behaviors of Alzheimer's disease.
    Lanctôt KL; Herrmann N; Eryavec G; van Reekum R; Reed K; Naranjo CA
    Neuropsychopharmacology; 2002 Oct; 27(4):646-54. PubMed ID: 12377401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-HT2a/2c receptor blockade by amesergide fully attenuates prolactin response to d-fenfluramine challenge in physically healthy human subjects.
    Coccaro EF; Kavoussi RJ; Oakes M; Cooper TB; Hauger R
    Psychopharmacology (Berl); 1996 Jul; 126(1):24-30. PubMed ID: 8853213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.